Advertise
Urology Times® offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Let's work together - Contact Us!
Advertisement
Advertisement
Trending on Urology Times
1
Updated CAPItello-281 data show numerical OS benefit with capivasertib in PTEN-deficient mHSPC
2
Adding darolutamide to ADT and radiation improves MFS in very high-risk localized prostate cancer
3
Durvalumab plus BCG improves DFS in papillary-only, BCG-naïve NMIBC
4
Alberto Briganti, MD, PhD, on the PROTEUS substudy in high-risk prostate cancer
5